| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0070-2153(03)54004-2 |
| P698 | PubMed publication ID | 12696745 |
| P50 | author | Carlos López Otín | Q2919877 |
| P2093 | author name string | Duanqing Pei | |
| Jian Cao | |||
| Stanley Zucker | |||
| P2860 | cites work | Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members | Q22001456 |
| Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors | Q22009965 | ||
| Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors | Q22253287 | ||
| Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP | Q24290409 | ||
| Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury | Q24290646 | ||
| Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes | Q24292053 | ||
| Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family | Q24310476 | ||
| A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 | ||
| Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases | Q24550531 | ||
| Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55 | Q24595955 | ||
| Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms | Q24623052 | ||
| Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor | Q27729709 | ||
| Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 | Q27742927 | ||
| Furin-dependent intracellular activation of the human stromelysin-3 zymogen | Q28115242 | ||
| cDNA Sequence and mRNA Tissue Distribution of a Novel Human Matrix Metalloproteinase with a Potential Transmembrane Segment | Q28115693 | ||
| Cloning of three Caenorhabditis elegans genes potentially encoding novel matrix metalloproteinases | Q28116117 | ||
| Tissue inhibitors of metalloproteinases: evolution, structure and function | Q28138083 | ||
| Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation | Q28138867 | ||
| Tenascin-C in development and disease: gene regulation and cell function | Q28139238 | ||
| Matrix metalloproteinases | Q28140451 | ||
| Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII | Q28142828 | ||
| Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization | Q28145656 | ||
| Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases | Q28198043 | ||
| Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration | Q28203290 | ||
| Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome | Q28204201 | ||
| Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients | Q28206832 | ||
| The hemopexin-like C-terminal domain of membrane type 1 matrix metalloproteinase regulates proteolysis of a multifunctional protein, gC1qR | Q28214381 | ||
| Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. | Q28215016 | ||
| Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13) | Q28236176 | ||
| Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5 | Q28242922 | ||
| Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA | Q28256375 | ||
| Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP) | Q28258413 | ||
| Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain | Q28278203 | ||
| Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme | Q28282027 | ||
| The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family | Q28293228 | ||
| Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively | Q28306053 | ||
| Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain | Q28307087 | ||
| Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species | Q28367213 | ||
| The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis | Q28504785 | ||
| Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation | Q28509009 | ||
| TIMP-2 is required for efficient activation of proMMP-2 in vivo | Q28512714 | ||
| Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7) | Q28564762 | ||
| Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation | Q28587897 | ||
| The proprotein convertases | Q28609903 | ||
| Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain | Q28610274 | ||
| Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release | Q28611028 | ||
| Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases | Q28611036 | ||
| Matrix metalloproteinase degradation of extracellular matrix: biological consequences | Q28611041 | ||
| Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network | Q28616788 | ||
| Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease | Q28618841 | ||
| Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity | Q28618997 | ||
| The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study | Q28619177 | ||
| Matrix metalloproteinases: effectors of development and normal physiology | Q28679038 | ||
| New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
| Identification of substrate sequences for membrane type-1 matrix metalloproteinase using bacteriophage peptide display library | Q30641764 | ||
| Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins | Q34479986 | ||
| Localization of the human membrane type 4-matrix metalloproteinase gene (MMP17) to chromosome 12q24. | Q34486182 | ||
| Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas | Q34497741 | ||
| Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
| Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase | Q34786196 | ||
| Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers | Q35753435 | ||
| Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes | Q35765296 | ||
| MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells | Q59571869 | ||
| Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of ?2?1 integrins | Q59591366 | ||
| Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines | Q59591367 | ||
| Role of MT-MMPs and MMP-2 in pancreatic cancer progression | Q60609532 | ||
| Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis | Q64379930 | ||
| Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture | Q68272557 | ||
| Assignment of the human membrane-type matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization | Q70807863 | ||
| Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury | Q71006325 | ||
| MT-MMP expression and localisation in human lung and breast cancers | Q71116140 | ||
| Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP) | Q71118438 | ||
| Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction | Q71637835 | ||
| Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis | Q71743251 | ||
| Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis | Q71820200 | ||
| Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy | Q71821481 | ||
| Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain | Q71825162 | ||
| Expression of membrane-type matrix metalloproteinase in human gastric carcinomas | Q71887264 | ||
| Basement Membrane Collagen: Degradation by Migrating Endothelial Cells | Q72699515 | ||
| The distribution of epidermal growth factor binding sites in the developing mouse palate | Q72734558 | ||
| MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover | Q73082300 | ||
| Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator | Q73082573 | ||
| Matrix matters | Q73085842 | ||
| Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments | Q73101332 | ||
| Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton | Q73119529 | ||
| Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis | Q73204885 | ||
| Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity | Q73212038 | ||
| Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells | Q73221005 | ||
| Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model | Q73265468 | ||
| Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells | Q73286853 | ||
| Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. | Q30656169 | ||
| Expression and localization of transcripts of MT5-MMP and its related MMP in the ovary of the medaka fish Oryzias latipes | Q30660273 | ||
| Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3). | Q30663571 | ||
| Determination of protease cleavage site motifs using mixture-based oriented peptide libraries | Q30702360 | ||
| Tumor targeting with a selective gelatinase inhibitor | Q30747366 | ||
| Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model | Q32148378 | ||
| Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line | Q33179117 | ||
| Matrix metalloproteinases: a tail of a frog that became a prince | Q33337157 | ||
| Membrane-type matrix metalloproteinases | Q33586502 | ||
| Regulation of matrix metalloproteinase expression in tumor invasion. | Q33605726 | ||
| Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention | Q33606833 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Extracellular matrix degradation by metalloproteinases and central nervous system diseases | Q33737455 | ||
| Proteolysis and cell migration: creating a path? | Q33744936 | ||
| Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis | Q33782645 | ||
| The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis | Q33783677 | ||
| Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. | Q33843796 | ||
| Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. | Q33880837 | ||
| Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor. | Q33885867 | ||
| Changing concepts of atherogenesis | Q33890391 | ||
| Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target | Q33895469 | ||
| Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. | Q33900860 | ||
| Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation | Q33914246 | ||
| Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). | Q33935969 | ||
| Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils | Q33941026 | ||
| Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells | Q33943172 | ||
| Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis | Q33949968 | ||
| Tumor angiogenesis: thrombin and metalloproteinases in focus | Q33966003 | ||
| Matrix metalloproteinases in tumor invasion and metastasis | Q34136635 | ||
| Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment | Q34293595 | ||
| The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. | Q34384684 | ||
| Cellular strategies for proteolytic targeting during migration and invasion | Q34395533 | ||
| Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema | Q34457903 | ||
| Tumorigenic potential of extracellular matrix metalloproteinase inducer | Q35842240 | ||
| Activity of type IV collagenases in benign and malignant breast disease | Q35976755 | ||
| Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential | Q36085224 | ||
| Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter | Q36255730 | ||
| Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A | Q36274038 | ||
| TGF-beta3-induced palatogenesis requires matrix metalloproteinases | Q36284069 | ||
| Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. | Q36328263 | ||
| Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes | Q36369835 | ||
| Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo | Q36376907 | ||
| A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation | Q36381389 | ||
| Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain | Q36700680 | ||
| Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product | Q36847047 | ||
| Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction | Q37527656 | ||
| Calreticulin is directly involved in anti-alpha3 integrin antibody-mediated secretion and activation of matrix metalloprotease-2. | Q38301395 | ||
| Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice | Q38525299 | ||
| Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes | Q38785129 | ||
| Proteinases in cardiovascular aneurysms and rupture: targets for therapy? | Q40365142 | ||
| Matrix metalloproteinases and cardiovascular disease | Q40410789 | ||
| Structural features of a superfamily of zinc-endopeptidases: the metzincins | Q40428339 | ||
| Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme | Q40732890 | ||
| Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase | Q40758551 | ||
| Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway | Q40777137 | ||
| Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. | Q40778640 | ||
| Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. | Q40789097 | ||
| Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation | Q40790178 | ||
| Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration | Q40802553 | ||
| The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain | Q40818712 | ||
| Down-Regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion | Q40822760 | ||
| Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system | Q40852287 | ||
| Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. | Q40853467 | ||
| In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. | Q40868335 | ||
| Hepatocyte growth factor enhances MMP activity in human endothelial cells | Q40873055 | ||
| Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. | Q40886684 | ||
| Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. | Q40893331 | ||
| Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2. | Q40916497 | ||
| Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells | Q40947666 | ||
| Proteolytic remodeling of extracellular matrix | Q40952583 | ||
| Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability | Q40955756 | ||
| Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line | Q40984834 | ||
| Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface | Q41013800 | ||
| Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells | Q41020537 | ||
| Expression and localization of membrane type matrix metalloproteinase-1 (MT1-MMP) in trophoblast cells of cultured mouse blastocysts and ectoplacental cones | Q41063211 | ||
| c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells | Q41116569 | ||
| Cell-cell contact down-regulates expression of membrane type metalloproteinase-1 (MT1-MMP) in a mouse mammary gland epithelial cell line | Q41128912 | ||
| Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules | Q41133261 | ||
| Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis | Q41178387 | ||
| Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. | Q41184688 | ||
| The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation | Q41380842 | ||
| Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis | Q41602595 | ||
| Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites | Q41639991 | ||
| Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase | Q41646524 | ||
| Matrix metalloproteinases and coronary artery disease: a novel therapeutic target | Q41722548 | ||
| Extraction of type-IV collagenase/gelatinase from plasma membranes of human cancer cells | Q41730868 | ||
| Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). | Q41868757 | ||
| The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases | Q41943469 | ||
| Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype | Q41943857 | ||
| Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors | Q42048997 | ||
| Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system | Q42158569 | ||
| Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma | Q42279639 | ||
| Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts | Q42279993 | ||
| Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia | Q42482174 | ||
| Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions | Q42495701 | ||
| Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor | Q42653828 | ||
| A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. | Q42806172 | ||
| Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells | Q42855929 | ||
| Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains | Q42998517 | ||
| Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition | Q43508547 | ||
| Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity | Q43636531 | ||
| Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling | Q43670946 | ||
| Insight into the complex and dynamic process of activation of matrix metalloproteinases | Q43677712 | ||
| A conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone | Q43796757 | ||
| An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase | Q43821714 | ||
| MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen | Q43845368 | ||
| Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. | Q44248212 | ||
| Cancer cell invasion and metastasis | Q44379278 | ||
| MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells | Q46095406 | ||
| Structural and enzymatic characterization of Drosophila Dm2-MMP, a membrane-bound matrix metalloproteinase with tissue-specific expression. | Q47071821 | ||
| The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation | Q47761007 | ||
| Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes | Q47810211 | ||
| Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development | Q47833577 | ||
| Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization | Q47848846 | ||
| Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain | Q47850733 | ||
| Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts | Q47878293 | ||
| Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas | Q47880855 | ||
| Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells | Q47903075 | ||
| Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent. | Q47930008 | ||
| Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation | Q48040095 | ||
| The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis | Q48043742 | ||
| Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. | Q48159635 | ||
| Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. | Q48173251 | ||
| Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer | Q48561841 | ||
| Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles. | Q51197764 | ||
| Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. | Q52175351 | ||
| Cloning and developmental expression of a membrane-type matrix metalloproteinase from chicken. | Q52199399 | ||
| Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. | Q52539773 | ||
| Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism. | Q52541045 | ||
| White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues. | Q53210682 | ||
| Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. | Q55474490 | ||
| Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. | Q55475249 | ||
| Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase | Q57167800 | ||
| Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis | Q74340538 | ||
| Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells | Q74350293 | ||
| Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas | Q74351891 | ||
| Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket | Q74457179 | ||
| CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration | Q74528310 | ||
| Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP) | Q77086987 | ||
| Vascular extracellular matrix remodeling in cerebral aneurysms | Q77180718 | ||
| Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface | Q77228964 | ||
| Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340) | Q77300084 | ||
| Matrix metalloproteases: variations on a theme | Q77455726 | ||
| Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells | Q77472189 | ||
| Membrane-type metalloproteinases in tumor invasion | Q77635815 | ||
| The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis | Q77639447 | ||
| Two-step sandwich enzyme immunoassay using monoclonal antibodies for detection of soluble and membrane-associated human membrane type 1-matrix metalloproteinase | Q77645044 | ||
| SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines | Q77670137 | ||
| Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase | Q77682531 | ||
| MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization | Q77874142 | ||
| New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above | Q77922271 | ||
| Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas | Q77931928 | ||
| Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas | Q77947962 | ||
| Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene | Q77953566 | ||
| Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation | Q78009358 | ||
| Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium | Q78069867 | ||
| Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas | Q78161400 | ||
| Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2 | Q73288795 | ||
| Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium | Q73302075 | ||
| MMP-2 colocalizes with caveolae on the surface of endothelial cells | Q73306221 | ||
| Hypercholesterolemia causes mechanical weakening of rabbit atheroma : local collagen loss as a prerequisite of plaque rupture | Q73333660 | ||
| Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas | Q73352931 | ||
| Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts | Q73381249 | ||
| Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A | Q73445365 | ||
| Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion | Q73474651 | ||
| Analysis of MT1-MMP and MMP2 expression in human gastric cancers | Q73507947 | ||
| Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation | Q73581114 | ||
| Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis | Q73581133 | ||
| Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines | Q73643352 | ||
| Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP | Q73720926 | ||
| All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo | Q73739972 | ||
| Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells | Q73832884 | ||
| Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium | Q73833090 | ||
| Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier | Q73842972 | ||
| Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells | Q73855117 | ||
| Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells | Q73883829 | ||
| Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery | Q73901878 | ||
| Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis | Q73904628 | ||
| Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression | Q73949261 | ||
| Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis | Q73949287 | ||
| cAMP involvement in the expression of MMP-2 and MT-MMP1 metalloproteinases in human endothelial cells | Q73965958 | ||
| The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells | Q73977875 | ||
| Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells | Q73995916 | ||
| Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries | Q74093557 | ||
| Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo | Q74103792 | ||
| Membrane type-1 matrix metalloprotease and stromelysin-3 cleave more efficiently synthetic substrates containing unusual amino acids in their P1' positions | Q74105851 | ||
| Production of membrane-type matrix metalloproteinase-1 (MT-MMP-1) in early human placenta. A possible role in placental implantation? | Q74106703 | ||
| Don't mess with the matrix | Q74115790 | ||
| Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells | Q74129035 | ||
| Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade | Q74148127 | ||
| MT1-MMP on the cell surface causes focal degradation of gelatin films | Q74191580 | ||
| Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling | Q74214731 | ||
| Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung | Q74219130 | ||
| MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts | Q74268786 | ||
| Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts | Q74279403 | ||
| Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation | Q74292354 | ||
| Reduced angiogenesis and tumor progression in gelatinase A-deficient mice | Q74309789 | ||
| Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma | Q74314745 | ||
| Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation | Q74318565 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-74 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Current Topics in Developmental Biology | Q15745419 |
| P1476 | title | Membrane type-matrix metalloproteinases (MT-MMP) | |
| P478 | volume | 54 |
| Q38716428 | A Transcriptional Regulatory Role for the Membrane Type-1 Matrix Metalloproteinase in Carcinogen-Induced Inflammasome Gene Expression |
| Q37614524 | A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1-MMP. |
| Q36985012 | Breast cancer progression: insights into multifaceted matrix metalloproteinases. |
| Q34463039 | Centrosomal pericentrin is a direct cleavage target of membrane type-1 matrix metalloproteinase in humans but not in mice: potential implications for tumorigenesis. |
| Q35312025 | Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase |
| Q34297111 | Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking |
| Q37090633 | Development of an optimized activatable MMP-14 targeted SPECT imaging probe. |
| Q41677415 | Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo |
| Q28512081 | Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation |
| Q36644315 | Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. |
| Q38126397 | Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking |
| Q36138051 | Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system |
| Q40216249 | Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4-MMP) in breast cancer cells. |
| Q36220259 | Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. |
| Q35110491 | Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer |
| Q26826431 | Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance |
| Q51097580 | Expression and Purification of a Matrix Metalloprotease Transmembrane Domain in Escherichia coli. |
| Q41679116 | Furin Functions as a Nonproteolytic Chaperone for Matrix Metalloproteinase-28: MMP-28 Propeptide Sequence Requirement |
| Q24337919 | Golgi reassembly stacking protein 55 interacts with membrane-type (MT) 1-matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1-MMP zymogen |
| Q53351891 | Helicobacter pylori encoding the pathogenicity island activates matrix metalloproteinase 1 in gastric epithelial cells via JNK and ERK. |
| Q36240167 | Hsp70 Knockdown by siRNA Decreased Collagen Production in Keloid Fibroblasts. |
| Q39927605 | Identification and role of the homodimerization interface of the glycosylphosphatidylinositol-anchored membrane type 6 matrix metalloproteinase (MMP25) |
| Q39524980 | Influence of β-catenin small interfering RNA on human osteosarcoma cells |
| Q35313033 | Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. |
| Q34418625 | Localizing matrix metalloproteinase activities in the pericellular environment |
| Q37848282 | Looking at the proteases from a simple perspective. |
| Q24683414 | MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties |
| Q35529307 | MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK. |
| Q35025845 | MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis |
| Q37366248 | MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis |
| Q37088968 | MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer |
| Q36125093 | Matrix Metalloproteinases and Bladder Cancer: What is New? |
| Q36324512 | Matrix metalloproteinases - From the cleavage data to the prediction tools and beyond |
| Q33797703 | Matrix metalloproteinases, T cell homing and beta-cell mass in type 1 diabetes. |
| Q38143977 | Melanoma biomolecules: independently identified but functionally intertwined. |
| Q35587684 | Membrane associated proteases and their inhibitors in tumour angiogenesis |
| Q36911913 | Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis |
| Q40425742 | Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability |
| Q47073274 | Membrane-type 1 matrix metalloproteinase regulates cell migration during zebrafish gastrulation: evidence for an interaction with non-canonical Wnt signaling |
| Q40479187 | Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells. |
| Q34324885 | Metalloendoprotease cleavage triggers gelsolin amyloidogenesis |
| Q28512433 | Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation |
| Q38816478 | MicroRNA miR-182 cluster mediated modulation of RECK without changes in cell surface membrane type-1 matrix metalloproteinase (MT1-MMP). |
| Q38991475 | Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients |
| Q91633965 | Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis |
| Q42239363 | New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. |
| Q46617653 | Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the complement component C1q. |
| Q34190659 | Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth |
| Q40289813 | O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP). |
| Q35618331 | Ovarian membrane-type matrix metalloproteinases: induction of MMP14 and MMP16 during the periovulatory period in the rat, macaque, and human |
| Q26765807 | Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke |
| Q33638953 | Peptide aptamers as new tools to modulate clathrin-mediated internalisation--inhibition of MT1-MMP internalisation |
| Q38725320 | Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment |
| Q44375832 | Planar cell polarity proteins differentially regulate extracellular matrix organization and assembly during zebrafish gastrulation |
| Q55398181 | Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy. |
| Q39408199 | Platelets, circulating tumor cells, and the circulome. |
| Q39682060 | Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP |
| Q73762923 | Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes |
| Q35778090 | ProMMP-2: TIMP-1 complexes identified in plasma of healthy individuals |
| Q40067505 | Proteolysis of the membrane type-1 matrix metalloproteinase prodomain: implications for a two-step proteolytic processing and activation. |
| Q37465475 | Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy |
| Q34702697 | Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2. |
| Q33619160 | Retracted: A Femtomol Range FRET Biosensor Reports Exceedingly Low Levels of Cell Surface Furin: Implications for the Processing of Anthrax Protective Antigen |
| Q33793942 | Role of c-Src activity in the regulation of gastric cancer cell migration |
| Q45265587 | Single-nucleotide polymorphisms and haplotypes of membrane type 1-matrix metalloproteinase in susceptibility and clinical significance of squamous cell neoplasia of uterine cervix in Taiwan women |
| Q42232053 | Skin Wound Healing Effects and Action Mechanism of Acai Berry Water Extracts |
| Q35760031 | Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas |
| Q35708443 | The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity |
| Q28066054 | The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression |
| Q38728851 | The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells |
| Q39502453 | The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines. |
| Q41851227 | The enzyme profiles in the connective tissue attaching pin bones to the surrounding tissue is specific in farmed salmon (Salmo salar) and cod (Gadus morhua L.). |
| Q36719208 | The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP. |
| Q35113424 | The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis |
| Q33850661 | The membrane proteome of sensory cilia to the depth of olfactory receptors |
| Q44691513 | The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. |
| Q38273202 | The significance of matrix metalloproteinases in parasitic infections involving the central nervous system |
| Q38570277 | The thymus microenvironment in regulating thymocyte differentiation. |
| Q39833926 | Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells |
| Q46021184 | Treponema denticola increases MMP-2 expression and activation in the periodontium via reversible DNA and histone modifications. |
| Q34338097 | Zymographic and ultrastructural evaluations after low-level laser irradiation on masseter muscle of HRS/J strain mice |
| Q35811902 | miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14. |
Search more.